{"entity":{"type":"insider","cik":"0001834161","url":"/insider/0001834161","json_url":"/insider/0001834161.json","name":"Eisner Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2023-03-06","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Eisner Mark","source":"filing","n_filings":8,"first_seen":"2023-03-06","last_seen":"2026-02-26"}],"transactions":[{"id":6094929,"accession":"0001628280-26-012394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-012394","line_url":"/filing/0001628280-26-012394#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1889.0,"shares_display":"1,889","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":18549.98,"total_display":"18,549.98","total_whole":"18,550","shares_owned_after":154024.0,"shares_owned_after_display":"154,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6094925,"accession":"0001628280-26-012394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-012394","line_url":"/filing/0001628280-26-012394#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":9.5326,"price_display":"9.53","price_state":"stated","total_value":15404.6816,"total_display":"15,404.68","total_whole":"15,405","shares_owned_after":155913.0,"shares_owned_after_display":"155,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":5802159,"accession":"0001628280-26-011329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-011329","line_url":"/filing/0001628280-26-011329#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2089.0,"shares_display":"2,089","price_per_share":7.4528,"price_display":"7.45","price_state":"stated","total_value":15568.8992,"total_display":"15,568.90","total_whole":"15,569","shares_owned_after":157529.0,"shares_owned_after_display":"157,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":5173951,"accession":"0001628280-25-035269","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-035269","line_url":"/filing/0001628280-25-035269#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3586.0,"shares_display":"3,586","price_per_share":5.4738,"price_display":"5.47","price_state":"stated","total_value":19629.0468,"total_display":"19,629.05","total_whole":"19,629","shares_owned_after":104618.0,"shares_owned_after_display":"104,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-17","scope":"insider"},{"id":5173946,"accession":"0001628280-25-035269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-035269","line_url":"/filing/0001628280-25-035269#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6796.0,"shares_display":"6,796","price_per_share":5.4682,"price_display":"5.47","price_state":"stated","total_value":37161.8872,"total_display":"37,161.89","total_whole":"37,162","shares_owned_after":108204.0,"shares_owned_after_display":"108,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-17","scope":"insider"},{"id":8469359,"accession":"0001209191-23-036054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-036054","line_url":"/filing/0001209191-23-036054#line-1","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2042.0,"shares_display":"2,042","price_per_share":17.038,"price_display":"17.04","price_state":"stated","total_value":34791.596,"total_display":"34,791.60","total_whole":"34,792","shares_owned_after":162862.0,"shares_owned_after_display":"162,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":8403864,"accession":"0001209191-23-034288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034288","line_url":"/filing/0001209191-23-034288#line-1","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1090.0,"shares_display":"1,090","price_per_share":18.83,"price_display":"18.83","price_state":"stated","total_value":20524.7,"total_display":"20,524.70","total_whole":"20,525","shares_owned_after":164904.0,"shares_owned_after_display":"164,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":8437895,"accession":"0001209191-23-023592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023592","line_url":"/filing/0001209191-23-023592#line-1","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9182.0,"shares_display":"9,182","price_per_share":18.7838,"price_display":"18.78","price_state":"stated","total_value":172472.8516,"total_display":"172,472.85","total_whole":"172,473","shares_owned_after":165994.0,"shares_owned_after_display":"165,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-06","scope":"insider"},{"id":8152608,"accession":"0001209191-23-018063","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-018063","line_url":"/filing/0001209191-23-018063","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10140.0,"shares_display":"10,140","price_per_share":20.1973,"price_display":"20.20","price_state":"stated","total_value":204800.622,"total_display":"204,800.62","total_whole":"204,801","shares_owned_after":175176.0,"shares_owned_after_display":"175,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-10","scope":"insider","n_lines":2},{"id":8152600,"accession":"0001209191-23-018063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-018063","line_url":"/filing/0001209191-23-018063#line-3","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7363.0,"shares_display":"7,363","price_per_share":21.1559,"price_display":"21.16","price_state":"stated","total_value":155770.8917,"total_display":"155,770.89","total_whole":"155,771","shares_owned_after":165133.0,"shares_owned_after_display":"165,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-10","scope":"insider"},{"id":7994740,"accession":"0001209191-23-016362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016362","line_url":"/filing/0001209191-23-016362#line-1","is_derivative":false,"issuer_cik":"0000921299","issuer_name":"FIBROGEN INC","issuer_ticker":"FGEN","issuer_name_source":null,"issuer_url":"/issuer/0000921299","owner_cik":"0001834161","owner_name":"Eisner Mark","owner_display_name":"Eisner Mark","owner_url":"/insider/0001834161","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":21.87,"price_display":"21.87","price_state":"stated","total_value":25959.69,"total_display":"25,959.69","total_whole":"25,960","shares_owned_after":172496.0,"shares_owned_after_display":"172,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Officer (EVP and Chief Medical Officer)","n_filings":3,"first_seen":"2025-07-17","last_seen":"2026-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000921299","name":"FIBROGEN INC","url":"/issuer/0000921299","role":"Officer (EVP, Chief Medical Officer)","n_filings":5,"first_seen":"2023-03-06","last_seen":"2023-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001834161","retrieved_at":"2026-08-27T08:41:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}